NFA
GHDX

Nationwide Fund Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Nationwide Fund Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,887
Closed -$349K – 2759
2017
Q3 		$349K Hold
10,887
– – ﹤0.01% 2367
2017
Q2 		$354K Hold
10,887
– – ﹤0.01% 2356
2017
Q1 		$343K Sell
10,887
-1,045
-9% -$30.9K ﹤0.01% 2358
2016
Q4 		$351K Hold
11,932
– – ﹤0.01% 2354
2016
Q3 		$345K Hold
11,932
– – ﹤0.01% 2355
2016
Q2 		$309K Buy
11,932
+351
+3% +$9.32K ﹤0.01% 2396
2016
Q1 		$287K Sell
11,581
-60
-0.5% -$1.65K ﹤0.01% 2367
2015
Q4 		$410K Buy
11,641
+239
+2% +$6.4K ﹤0.01% 2211
2015
Q3 		$241K Hold
11,402
– – ﹤0.01% 2474
2015
Q2 		$317K Sell
11,402
-882
-7% -$24.9K ﹤0.01% 2485
2015
Q1 		$375K Sell
12,284
-472
-4% -$15K ﹤0.01% 2384
2014
Q4 		$408K Sell
12,756
-166
-1% -$5.4K ﹤0.01% 2300
2014
Q3 		$366K Buy
12,922
+9
+0.1% +$251 ﹤0.01% 2391
2014
Q2 		$354K Buy
12,913
+10
+0.1% +$266 ﹤0.01% 2459
2014
Q1 		$340K Hold
12,903
– – ﹤0.01% 2248
2013
Q4 		$378K Sell
12,903
-399
-3% -$12.7K ﹤0.01% 2366
2013
Q3 		$407K Buy
13,302
+910
+7% +$30.4K ﹤0.01% 2324
2013
Q2 		$393K Buy
+12,392
New +$407K ﹤0.01% 2129

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nationwide Fund Advisors's GHDX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2017, closing a stake of 10,887 shares — an estimated $349K sold.

Nationwide Fund Advisors first reported a position in GHDX in Q2 2013 and held it in 18 quarters. The position peaked at $410K in Q4 2015. 135 funds tracked by Wall St. Rank hold GHDX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Genomic Health, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 10,887 Genomic Health, Inc. shares in Q4 2017, an estimated $349K.
  • Nationwide Fund Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Genomic Health, Inc. position peaked at $410K in Q4 2015.
  • 135 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.